Intra-Arterial Thrombolysis Within 3 Hours:
Where Is the Evidence?
To the Editor:
We have read with interest the article, "Intra-arterial thrombolysis within 3 hours after acute ischemic stroke in selected patients," 1 in the Controversies in Stroke section, wherein the authors cite the Interventional Management of Stroke Study to claim that combined intravenous and intra-arterial therapy with recombinant tissue-type plasminogen activator, when used in 28 patients with carotid occlusion, led to recanalization in 56% of them, and this correlates with clinical outcome (Rankin score 0 to 1). 1 We fail to understand how the authors reached this conclusion. In the Interventional Management of Stroke-1 Study, of 28 patients with carotid occlusion or severe stenosis, 16 (57%) had Thrombolysis in Myocardial Infarction 2 to 3 or 3 grade recanalization, but outcome (modified Rankin score 0 to 1) was observed in only 4 (14%) of these patients. 2 Readers need to be cautious in interpreting the present data (the Table) . To settle the present controversy, we need a trial comparing intravenous and intra-arterial thrombolytic modes of therapy.
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